| abstract |
The present invention relates to rapid clearance molecules that bind target antigens and FcyRMb with increased affinity as compared to parent molecules, said compositions being capable of causing accelerated clearance of such antigens. Such compositions are useful for treating a variety of disorders, including allergic diseases, atherosclerosis, and a variety of other conditions. |